Raymond James Financial Services Advisors Inc. Has $287,000 Stock Holdings in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Raymond James Financial Services Advisors Inc. decreased its stake in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 14.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 3,770 shares of the company’s stock after selling 636 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Invesco Pharmaceuticals ETF were worth $287,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of PJP. Horizon Bancorp Inc. IN bought a new position in shares of Invesco Pharmaceuticals ETF in the 3rd quarter valued at about $59,000. Geneos Wealth Management Inc. lifted its stake in Invesco Pharmaceuticals ETF by 613.3% in the 3rd quarter. Geneos Wealth Management Inc. now owns 1,070 shares of the company’s stock valued at $77,000 after purchasing an additional 920 shares during the last quarter. Modera Wealth Management LLC acquired a new stake in Invesco Pharmaceuticals ETF in the 3rd quarter valued at about $538,000. Cambridge Investment Research Advisors Inc. lifted its stake in Invesco Pharmaceuticals ETF by 206.0% in the 3rd quarter. Cambridge Investment Research Advisors Inc. now owns 41,273 shares of the company’s stock valued at $2,987,000 after purchasing an additional 27,786 shares during the last quarter. Finally, UBS Group AG lifted its stake in Invesco Pharmaceuticals ETF by 132.2% in the 3rd quarter. UBS Group AG now owns 92,123 shares of the company’s stock valued at $6,667,000 after purchasing an additional 52,455 shares during the last quarter.

Invesco Pharmaceuticals ETF Stock Performance

Shares of NYSEARCA:PJP opened at $75.99 on Tuesday. Invesco Pharmaceuticals ETF has a 52-week low of $67.75 and a 52-week high of $80.65. The company has a market capitalization of $266.71 million, a P/E ratio of 20.52 and a beta of 0.64. The company has a 50-day simple moving average of $77.93 and a 200 day simple moving average of $74.91.

Invesco Pharmaceuticals ETF Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.